Benvyon 25 mg

Benvyon 25 mg is a solution containing bendamustine hydrochloride, used for certain types of cancer treatment. This intravenous medication is manufactured by Pfizer Canada ULC.

Benvyon 25 mg is primarily used in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL). It works by interfering with the growth of cancer cells. Patients often wonder, 'What is Benvyon used for?' and the answer lies in its role as a chemotherapy agent for these specific conditions.

Common effects of Benvyon 25 mg may include nausea, fatigue, and low blood cell counts. Some patients might experience vomiting or infections. These effects can vary from person to person and are not exhaustive.

Benvyon 25 mg should be handled with care, as it is a potent medication. It is important to follow the advice of a healthcare professional regarding its use. Proper storage and administration are crucial to ensure safety.

Benvyon 25 mg may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.